Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 2/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10945046 | 0.93 | PTGDR2 (0.38) | HTR2CDRD2CHRNB4CHRNA3ALDH1A1 | |
| SCHEMBL9597736 | 0.91 | PTGDR2 (0.40) | HTR2CALDH1A1 | |
| SCHEMBL2887323 | 0.82 | HTR2C (0.48) | HTR2CMEN1KMT2A | |
| SCHEMBL8835486 | 0.80 | NQO1 (0.39) | ALDH1A1MEN1KMT2A | |
| SCHEMBL28826417 | 0.77 | CHRNB2 (0.35) | ALDH1A1KMT2A | |
| SCHEMBL28072594 | 0.77 | TRPV1 (0.36) | DRD2DRD3SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9093780 | 0.77 | LTA4H (0.41) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28874105 | 0.74 | CYP1A2 (0.34) | CA12CA1CA2CA7CA9 | |
| SCHEMBL457257 | 0.74 | HTR2C (0.32) | HTR2C | |
| SCHEMBL16955735 | 0.71 | CA1 (0.39) | HTR2CDRD2DRD3CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103368-A | EIF4E inhibitors and uses thereof | 皮克医疗公司 | 2024-05-28 | — | — | CN | disclosed |
| US-10986839-B2 | Substituted oxadiazoles for combating phytopathogenic fungi | BASF SE (DE) | 2021-04-27 | — | — | US | disclosed |
| US-20190159454-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2019-05-30 | — | — | US | disclosed |
| EP-3442951-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2019-02-20 | — | — | EP | disclosed |
| WO-2017178245-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2017-10-19 | — | — | WO | disclosed |
| CN-106573931-A | Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groups | 拜耳医药股份有限公司 | 2017-04-19 | — | — | CN | disclosed |
| US-6964974-B2 | 2,3-oxidosqualene-lanosterol cyclase inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2005-11-15 | — | — | US | disclosed |
| CN-1553900-A | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents | ��ʱ��ʩ����ҩ��˾ | 2004-12-08 | — | — | CN | disclosed |
| EP-0835242-A1 | THIOAMIDES S-OXIDES FOR USE AS PESTICIDES | Novartis AG (CH) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997000859-A1 | THIOAMIDES S-OXIDES FOR USE AS PESTICIDES | NOVARTIS AG (CH) | 1997-01-09 | — | — | WO | disclosed |
| US-5563168-A | FUNGICIDES, INSECTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-10-08 | — | — | US | disclosed |
| US-5387607-A | Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 1995-02-07 | — | — | US | disclosed |
| US-5292759-A | O-benzyloxime ethers and crop protection agents containing these compounds | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-08 | — | — | US | disclosed |
| US-5194662-A | Insecticides, fungicides for plants | BASF AKTIENGESELLSCHAFT (DE) | 1993-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190159454-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | CYP51A1, ERG28, DPM1 | HTR2C 3996/4885DRD2 1535/4885DRD3 975/4885 |
| US-10986839-B2 | Substituted oxadiazoles for combating phytopathogenic fungi | CYP51A1, ERG28, DPM1 | HTR2C 3996/4885DRD2 1535/4885DRD3 975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.